Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
Patricia Leckman sold 2,370 shares of ILMN on 18 February at $116.18 per share, worth a total of $275K. They now own 16,321 ILMN shares, or a 13% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.